Market Closed -
Other stock markets
|
Pre-market 07:59:31 am | |||
73.01 USD | +0.83% | 73.12 | +0.14% |
12:48pm | Xilio Therapeutics Plans Private Placement, Job Cuts | DJ |
12:34pm | Gilead Sciences in Exclusive License for Xilio Tumor-Activated IL-12 Program | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.88% | 90.95B | |
+33.50% | 701B | |
+26.24% | 571B | |
+0.78% | 381B | |
+20.85% | 334B | |
+16.38% | 319B | |
+2.72% | 210B | |
+0.98% | 210B | |
-6.65% | 201B | |
-3.51% | 157B |
- Stock
- Equities
- Stock Gilead Sciences, Inc. - Nasdaq
- News Gilead Sciences, Inc.
- Gilead Sciences Says Veklury Demonstrates Continued In Vitro Antiviral Activity Against Omicron